Current Projects

Pre-Pilot IV: Pacific Island Cancer and Obesity across the Lifespan (PICOLI) 

Pre-Pilot IV

Pacific Island Cancer and Obesity across the Lifespan (PICOLI) 

Project Leads: 
Michelle Laguana, PhD
Ashley Yamanaka, PhD

Project Summary:

The goal of this project is to prevent and manage chronic disease by creating new knowledge on the role of risk factors across the lifespan. This will be accomplished through analyzing data from successful studies to determine the role of obesity risk factors and eating patterns on obesity and obesity-related cancers across the lifespan. 
 Leveraging data from the BRISK, MEC, PICCAH, and CHL studies to conduct a comprehensive secondary data analysis, we aim to:

Specific Aims:

Aim 1
Identify population-specific predictors associated with obesity and obesity-related cancer in children and adults in Guam and Hawaii. Hypothesis 1: we hypothesize that predictors of obesity during childhood will be the same predictors of obesity and obesity-related cancers in adulthood. The steps will be to: (a) identify predictors of obesity and obesity-related cancer in adults using BRISK and MEC; (b) test the relationship between adult predictors (from BRISK and MEC) and child obesity (in CHL and PICCAH); (c) identify predictors of obesity and acanthosis nigricans in children; and (d) test the relationship between child obesity predictors (from CHL and PICCAH) and adult obesity and obesity-related cancer (from BRISK and MEC).

Pre-Pilot V: Discovery of Natural Products of Physalis peruviana (Poha) and Morinda citrifolia (Noni) against Fusobacterium nucleatum, a key pathogen associated with Colorectal Cancer

Pre-Pilot V

Discovery of Natural Products of Physalis peruviana (Poha) and Morinda citrifolia (Noni) against Fusobacterium nucleatum, a key pathogen associated with Colorectal Cancer 

Project Leads: 
Sahena Ferdosh, PhD
Leng Chang, MS, PhD

Project Summary:

The overall objective is to screen bioactive compounds from locally grown plants that will advance the development of cancer prevention and treatment. Our central hypothesis is that natural products from promising leads can inhibit oral pathogen F. nucleatum, a risk factor for CRC. We will also evaluate the anticancer properties of leads against colon cancer cell lines.

Specific Aims:

Aim 1
Extraction, fractionation and chemical characterization of the bioactive compounds from different parts of Noni using conventional and supercritical fluid extraction methods. 

Aim 2
Evaluation of the antimicrobial activity of fractionated compounds against F. nucleatum.  

Aim 3
To assess the anticancer properties of the identified compounds against colon cancer cell lines in vitro. 

Pilot II: Traditional and new lifestyle interventions for breast cancer prevention (TANICA) Individual plus policy systems and environment (I+PSE) Approach: A feasibility and acceptability study

Pilot II

Traditional and new lifestyle interventions for breast cancer prevention (TANICA) Individual plus policy systems and environment (I+PSE) Approach: A feasibility and acceptability study

Project Leads: 
Tanisha Aflague, PhD., RDN
Monica Esquivel, PhD., RDN, CSSD

Project Summary:

Colorectal cancer (CRC) is the second and third leading cause of cancer death in Hawai‘i and Guam respectively with the highest rates among males and Pacific Peoples (PP) (e.g. CHamoru, Filipinos). Colorectal cancer incidence in Hawai‘i is higher than the U.S. with the highest age-adjusted rates among Filipinos. In Guam, CHamoru have the highest age-adjusted mortality rates from CRC compared to other Asian and Pacific Islander groups. Screening and early detection to address CRC disparities in these populations are critical.

Specific Aims:

Aim 1
Establish and convene a Community Advisory Council (CAC) to identify policy, system, and environmental (PSE) priority areas for reducing obesity among female Native Hawaiian, CHamoru, and Filipino breast cancer survivors in Guam and Hawai‘i.

Aim 2
Examine the feasibility and acceptability of the TANICA pilot intervention for reducing obesity among female Native Hawaiian, CHamoru and Filipino breast cancer survivors in Guam and Hawai‘i.

Pilot III: Breast Cancer Risk Assessment in Hawaiʻi and the USAPI

Pilot III

Breast Cancer Risk Assessment in Hawaiʻi and the USAPI

Project Leads: 
John Shepherd, PhD
Grazyna Badowski, PhD

Project Summary:

This study is funded by the U54 Grant #5U54CA143727: University of Guam/University of Hawaii Cancer Center Partnership under Dr. Neal Palafox. Since 2003, the University of Hawaiʻi Cancer Center (UH Cancer Center) and the University of Guam (UOG) have worked in partnership to explore the reasons behind significant cancer health disparities among Pacific Islanders in Hawaiʻi, Guam and the neighboring U.S. Associated Pacific Islands (USAPI). The University of Guam/University of Hawaiʻi Cancer Center Partnership is one of only 14 Partnerships to Advance Cancer Health Equity (PACHE), a program of the NCI that supports cancer research capacity building at minority-serving institutions and collaborative research addressing cancer health disparities and their impact on underserved and socio-economically disadvantaged populations. The UOG/UH Cancer Center Partnership is the only PACHE serving Pacific Islanders (PI), with an emphasis on Micronesians. The partnership addresses cancer health disparities through research, training, and community outreach.

Specific Aims:

Aim 1
Explore the mechanisms and structure needed to curate unique clinical risk factors (age, BMI, family history, biopsy status, parity, first live birth age, HT use, menarche/menopause age) and clinical breast density in women undergoing breast cancer screening in Hawaii and Guam. Sub-hypothesis: The distribution of risk factors varies by region, race, and ethnicity in women with and without breast cancer.

Aim 2
Identify the unique breast density and imaging characteristics of women undergoing screening mammography in Hawaii and Guam. Sub-hypothesis: Breast density is uniquely associated with clinical risk factors, region, and race/ethnicity for women in Hawaii and the USAPI compared to non-Hispanic White women.​

Aim 3
Identify the trends in the prevalence of high breast cancer risk in AANHPI groups of women with and without breast cancer using established models compared to white women. Sub-hypothesis: The accuracy of current risk models are poor in AANHPI groups compared to white women.​

Link to Shepherd Research Lab website: <click here>

Past Projects

Pre-Pilot I: Traditional & New Lifestyle Interventions for Breast Cancer Prevention (TANICA)

Pre-Pilot I 

Traditional And New Lifestyle Interventions for Breast Cancer Prevention (TANICA)

Project Leads: 
Tanisha Aflague, PhD., RDN
Monica Esquivel, PhD., RDN, CSSD

Project Summary:

Breast cancer in both Guam and Hawai‘i is the second highest contributor to cancer mortality. Obesity disproportionately affects women of various ethnic and socioeconomic backgrounds, where rates of obesity among Native Hawaiian and CHamoru women are greater than non-Hispanic White and Filipino counterparts, respectively. Obese women diagnosed with breast cancer have an increased relative risk for recurrence (40 to 50%) and mortality (53 to 60%). Research on cancer survivorship has been independently linked to better survival after breast cancer with a healthy body weight, physical activity, a high fiber diet, and a lower intake of saturated fat. Collectively, physical activity and a healthy diet pattern contribute to a healthy body weight. Evidence suggests that lifestyle interventions that lead to weight loss can reduce breast cancer recurrence, yet no comprehensive lifestyle intervention exists for Guam and Hawai‘i.

Specific Aims:

Aim 1
Establish and convene a Community Advisory Council (CAC) to identify policy, system, and environmental (PSE) priority areas for reducing obesity among female Native Hawaiian, CHamoru, and Filipino breast cancer survivors in Guam and Hawai‘i.

Aim 2
Examine the feasibility and acceptability of the TANICA pilot intervention for reducing obesity among female Native Hawaiian, CHamoru and Filipino breast cancer survivors in Guam and Hawai‘i.

Pre-Pilot II: Colorectal Cancer Among CHamoru and Filipinos in Guam and Hawai‘i: Recommendations for Screening Interventions and Programs

Pre-Pilot II

Colorectal Cancer Among CHamoru and Filipinos in Guam and Hawai‘i: Recommendations for Screening Interventions and Programs

Project Leads: 
Tressa Diaz, PhD
Kevin Cassel,PhD

Project Summary:

Colorectal cancer (CRC) is the second and third leading cause of cancer death in Hawai‘i and Guam respectively with the highest rates among males and Pacific Peoples (PP) (e.g. CHamoru, Filipinos). Colorectal cancer incidence in Hawai‘i is higher than the U.S. with the highest age-adjusted rates among Filipinos. In Guam, CHamoru have the highest age-adjusted mortality rates from CRC compared to other Asian and Pacific Islander groups. Screening and early detection to address CRC disparities in these populations are critical.

This pre-pilot study will conduct in-depth research to examine knowledge and beliefs associated with CRC and screening, recommendations for community and culturally relevant prevention interventions, and the need for age-specific education interventions.

Specific Aims:

Aim 1
Determine the cognitive and cultural perspectives on colorectal cancer and screening among CHamoru and Filipinos living in Guam and Hawai‘i.

Aim 2
Assess acceptability of and recommendations for colorectal cancer screening education intervention methods among CHamoru and Filipinos.

Pre-Pilot III: New Insights Into Gastrointestinal (GI) Pathobiology for Native Hawaiians/Pacific Islanders

Pre-Pilot III 

New Insights Into Gastrointestinal (GI) Pathobiology for Native Hawaiians/Pacific Islanders

Project Leads: 
Deng Youping, PhD
Peiwen Fei, MD, PhD
Tedros Bezabeh, PhD

Project Summary:

Colorectal cancer (CRC) health disparities exist in Native Hawaiians (NH) / Pacific Islanders (PI), particularly in the mortality rates. But this is currently understudied. We have studied race specific biological variations, which may offer valuable insights into CRC evolution and targets of intervention. Using RNA-seq, we found a set of biological variations unique to Native Hawaiians compared to the Whites of TCGA. Understanding CRC biological variations unique to NH/PI will be crucial to targeting and understanding the observed CRC health disparities

Specific Aims:

Aim 1
To discover new biological variations and validate those found in our preliminary studies unique to Native Hawaiians/Pacific Islanders with CRC

Pilot I: Cross-Sectional Analysis of Areca Alkaloids in Buccal Cells and Hair from Areca Nut Chewers as Candidate Biomarkers for Short and Long Term Areca Nut Exposure

Pilot I 

Cross-Sectional Analysis of Areca Alkaloids in Buccal Cells and Hair from Areca Nut Chewers as Candidate Biomarkers for Short and Long Term Areca Nut Exposure

Project Leads: 
Adrian Franke, PhD
Ana Joy Mendez, PhD, RN

Project Summary:

Areca nut (AN) chewing is an addictive and cancer-causing behavior practiced by hundreds of millions of people worldwide including in Guam. In this innovative study, we will compare levels of AN-specific compounds measured from the inner cheek cells and scalp hair from AN chewers in Guam to self-reported AN short- and long-term chewing habits. This unique approach will permit, for the first time, the objective approximation of when and how much AN was consumed. This, in turn, will greatly assist in AN cessation efforts, the most effective way to reduce AN-induced cancers.

 

Specific Aims:

Aim 1
Determine the relationship between areca alkaloid levels in BCs and scalp hair from chewers in Guam and their self-reported AN exposure (expressed as AANL) of the previous week (short term) and previous month and six months prior (long-term).

Aim 2
Determine whether the above correlations differ between class 1 and class 2 chewers. in Guam and Hawai‘i.

Full Project I: Adolescent Tobacco and Betel Nut Use Prevention in Guam

Full Project I

Adolescent Tobacco and Betel Nut Use Prevention in Guam

Project Leads: 
Francis Dalisay, PhD.
Pallav Pokhrel, PhD.

Project Summary:

High rates of tobacco and areca nut use in Guam and the rest of the U.S.-Affiliated Pacific Islands are of concern, especially in the context of the cancer disparities faced by the USAPI populations. Most tobacco/areca nut users initiate use during adolescence and our data suggests that adolescent tobacco product and betel nut use in Guam are alarmingly high compared to the U.S. nationally. This Project proposes to develop an adolescent tobacco and areca nut use prevention program for Guam youths. If successful, the program may be disseminated to the rest of the USAPI. The program may thus help curb the initiation of tobacco and areca nut use among USAPI adolescents and, by doing so, may reduce the high rates of cancer-related morbidity and mortality faced by the USAPI populations.

Specific Aims:

Aim 1
Primary: Test the efficacy of the school-based curriculum in a randomized controlled trial. Secondary: Test the effects of the social media-based campaign.

Aim 2
Develop a school-based curriculum and a social media based social marketing campaign for tobacco product (i.e., cigarette, e-cigarette, smokeless tobacco) and areca nut use prevention among middle school students in Guam.

Full Project II: Cyanotoxin and Liver Cancer Development in Two High-Risk Populations

Full Project II 

Cyanotoxin and Liver Cancer Development in Two High-Risk Populations

Project Leads: 
Laura Biggs, PhD
Brenda Hernandez, PhD, MPH

Project Summary:

Breast cancer inIndividuals from Hawaii and Guam have the highest rates of liver cancer in the U.S. Our proposed research will investigate the contribution of Cyanobacteria, the toxins they generate, and established risk factors to chronic liver disease (CLD). CLD is a major risk factor for the development of liver cancer. Cyanobacteria are naturally occurring bacteria that can be found in food and water sources. Their distribution on Guam is not well characterized. Preliminary data show that cyanotoxins can interact with established risk factors to influence liver cancer development. Established risk factors include hepatitis B and C, excessive alcohol consumption, and, more recently, metabolic syndrome (MetS)— including obesity, hyperlipidemia, insulin resistance, and non-alcoholic fatty liver disease (NAFLD).

Specific Aims:

Aim 1
To evaluate the association of oral Cyanobacteria and periodontal pathogens with liver fibrosis and steatosis and the modifying effects of viral hepatitis, alcohol, and MetS.

Aim 2
To evaluate the association of salivary and serum Cyanotoxins with liver fibrosis and steatosis and the modifying effects of viral hepatitis, alcohol, and MetS